Bausch Drug Patent Portfolio

Bausch owns 32 orange book drugs protected by 109 US patents with Cardizem Cd having the least patent protection, holding only 1 patent. And Jublia with maximum patent protection, holding 18 patents. Given below is the list of Bausch's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11389467 Topical compositions 28 Dec, 2040
Active
US11311482 Topical compositions and methods for treating skin diseases 11 May, 2038
Active
US11679116 Topical compositions and methods for treating psoriasis 06 Jun, 2036
Active
US10251895 Topical compositions and methods for treating psoriasis 06 Jun, 2036
Active
US10426787 Topical compositions and methods for treating psoriasis 06 Jun, 2036
Active
US11648256 Topical compositions and methods for treating psoriasis 06 Jun, 2036
Active
US11679115 Topical compositions and methods for treating psoriasis 06 Jun, 2036
Active
US10478601 Applicator 25 Apr, 2035
Active
US10342875 Stabilized efinaconazole compositions 02 Oct, 2034
Active
US10828293 Anti-infective methods, compositions, and devices 02 Oct, 2034
Active
US10864274 Stabilized efinaconazole formulations 02 Oct, 2034
Active
US11654139 Anti-infective methods, compositions, and devices 02 Oct, 2034
Active
US9662394 Stabilized efinaconazole compositions 02 Oct, 2034
Active
US8980931 Method of evaluating pharmaceutical preparation containing luliconazole and index substance 28 Apr, 2034
Active
US9012484 Crystal and pharmaceutical preparation containing the same crystal 06 Sep, 2033
Active
US9199977 Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal 06 Sep, 2033
Active
US9453006 Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient 06 Sep, 2033
Active
US9192615 Method for the treatment of acne and certain dosage forms thereof 17 Nov, 2031
Active
US10478502 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
Active
US11839656 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
Active
US11957753 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
Active
US11986527 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
Active
US12076403 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
Active
US8809307 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
Active
US8486978 Compositions and methods for treating diseases of the nail 24 Oct, 2030
Active
US9302009 Compositions and methods for treating diseases of the nail 24 Oct, 2030
Active
US10105444 Compositions and methods for treating diseases of the nail 08 Jul, 2030
Active
US8039494 Compositions and methods for treating diseases of the nail 08 Jul, 2030
Active
US9861698 Compositions and methods for treating diseases of the nail 08 Jul, 2030
Active
US10918635 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 30 Apr, 2030
Active
US11202752 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy 30 Apr, 2030
Active
US11850245 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 30 Apr, 2030
Active
US10238644 2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod 11 Dec, 2029
Active
US11318130 2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod 11 Dec, 2029
Active
US8222270 2×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod 11 Dec, 2029
Active
US8236816 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod 11 Dec, 2029
Active
US8299109 Method of treating actinic keratosis with 3.75% imiquimod cream 11 Dec, 2029
Active
US10238645 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 18 Aug, 2029
Active
US8598196 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy 18 Aug, 2029
Active
US8288434 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 05 Aug, 2029
Active
US10220049 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US10624918 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US8663699 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US8895070 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US9078870 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US9561208 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US10137142 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US9504704 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
Active
US10512640 Compositions and methods for treating diseases of the nail 03 Jan, 2028
Active
US10828369 Compositions and methods for treating diseases of the nail 03 Jan, 2028
Active
US11213519 Compositions and methods for treating diseases of the nail 03 Jan, 2028
Active
US11872218 Compositions and methods for treating diseases of the nail 03 Jan, 2028
Active
US9566272 Compositions and methods for treating diseases of the nail 03 Jan, 2028
Active
US9877955 Compositions and methods for treating diseases of the nail 03 Jan, 2028
Active
US7541347 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
Active
US7544373 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
Active
US7919483 Method for the treatment of acne 07 Mar, 2027
Active
US7378405 Stabilized steroid composition and method for its preparation 19 Dec, 2026
Active
US7241805 Modified release formulations of a bupropion salt 27 Jun, 2026
Active
US7569610 Modified release formulations of a bupropion salt 27 Jun, 2026
Active
US7572935 Modified release formulations of a bupropion salt 27 Jun, 2026
Active
US7585897 Modified release formulations of a bupropion salt 27 Jun, 2026
Active
US7645802 Bupropion hydrobromide and therapeutic applications 27 Jun, 2026
Active
US7649019 Modified release formulations of a bupropion salt 27 Jun, 2026
Active
US7662407 Modified release formulations of a bupropion salt 27 Jun, 2026
Active
US7671094 Bupropion hydrobromide and therapeutic applications 27 Jun, 2026
Active
US7214506 Method for treating onychomycosis 22 Feb, 2026
Active
US7790705 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
Active
US8252776 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
Active
US8268804 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
Active
US8722650 Extended-release minocycline dosage forms 24 Jun, 2025
Active
US7981877 Stabilized steroid composition and method for its preparation 23 Jan, 2025
Active
US7696159 Treatment for basal cell carcinoma 01 Oct, 2024 Expired
US7696159 Treatment for basal cell carcinoma 01 Apr, 2024 Expired
US8232264 Compositions and methods for enhancing corticosteroid delivery 09 Mar, 2023 Expired
US7220424 Compositions and methods for enhancing corticosteroid delivery 07 Jan, 2023 Expired
US7794738 Compositions and methods for enhancing corticosteroid delivery 11 Sep, 2022 Expired
US6765001 Compositions and methods for enhancing corticosteroid delivery 21 Dec, 2021 Expired
US7223387 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester 28 Feb, 2021 Expired
US6923984 Cushioning wax beads for making solid shaped articles 25 Feb, 2021 Expired
US6517847 Topical gel delivery system 03 Aug, 2020 Expired
US6387383 Topical low-viscosity gel composition 03 Aug, 2020 Expired
US5900488 Method for treating mycosis using imidazolylacetonitrile derivatives 18 Jan, 2020 Expired
US7108866 Chronotherapeutic diltiazem formulations and the administration thereof 17 Dec, 2019 Expired
US6423722 Crystalline macrolides and process for their preparation 26 Dec, 2018 Expired
US6096341 Delayed release tablet of bupropion hydrochloride 30 Oct, 2018 Expired
US6423722 Crystalline macrolides and process for their preparation 26 Jun, 2018 Expired
US5908838 Method for the treatment of acne 19 Feb, 2018 Expired
US6150337 Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes 21 Nov, 2017 Expired
US7981909 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis 16 Sep, 2017 Expired
US8227490 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis 16 Sep, 2017 Expired
US6514980 Nucleoside analogs in combination therapy of herpes simplex infections 24 Jan, 2017 Expired
US5912238 Heteroatoms-containing tricyclic compounds 15 Dec, 2016 Expired
US5962731 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors 05 Oct, 2016 Expired
US5955109 Methods and compositions for topical delivery of retinoic acid 21 Sep, 2016 Expired
US5912238 Heteroatoms-containing tricyclic compounds 15 Jun, 2016 Expired
US6352998 Pharmaceutical compositions 26 Apr, 2016 Expired
US6423342 Process for the preparation of a solid pharmaceutical dosage form 01 Mar, 2016 Expired
USRE39264 Pharmaceutical combination 02 Feb, 2016 Expired
US6352998 Pharmaceutical compositions 26 Oct, 2015 Expired
US5780676 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors 14 Jul, 2015 Expired
US5733886 Compositions of clindamycin and benzoyl peroxide for acne treatment 31 Mar, 2015 Expired
USRE41134 Slow release vehicles for minimizing skin irritancy of topical compositions 24 Feb, 2015 Expired
US5648093 Pharmaceutical and other dosage forms 15 Jul, 2014 Expired
US5462740 Rectally-administered, epileptic-seizure-inhibiting composition 17 Sep, 2013 Expired
US5536743 Intravaginal treatment of vaginal infections with buffered metronidazole compositions 16 Jul, 2013 Expired
US5529791 Extended release form of diltiazem 25 Jun, 2013 Expired
US5476875 Catechol derivatives 19 Dec, 2012 Expired
US5439689 Diltiazem formulation 08 Aug, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Bausch.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 21 May, 2024 US10864274
Payment of Maintenance Fee, 4th Year, Large Entity 18 Apr, 2024 US10828293
Payment of Maintenance Fee, 8th Year, Large Entity 18 Apr, 2024 US9504704 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 20 Mar, 2024 US8299109 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 20 Mar, 2024 US8288434 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 20 Mar, 2024 US8288434 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 20 Mar, 2024 US8288434 (Litigated)
Maintenance Fee Reminder Mailed 18 Mar, 2024 US8232264 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 29 Feb, 2024 US9453006
Payment of Maintenance Fee, 12th Year, Large Entity 20 Feb, 2024 US8268804 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 23 Jan, 2024 US8236816 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 23 Jan, 2024 US8252776 (Litigated)
Recordation of Patent eGrant 16 Jan, 2024 US11872218
Patent Issue Date Used in PTA Calculation 16 Jan, 2024 US11872218
Recordation of Patent Grant Mailed 16 Jan, 2024 US11872218


Bausch's Drug Patent Litigations

Bausch's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Sep 26, 1995, against patent number US5955109. The petitioner , challenged the validity of this patent, with WON et al as the respondent. Click below to track the latest information on how companies are challenging Bausch's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US11311482 June, 2023 Institution Denied
(12 Jan, 2024)
Bausch Health Ireland Limited et al. Padagis Israel Pharmaceuticals Ltd. et al.
US7214506 November, 2016 FWD Entered
(06 Jun, 2018)
Kaken Pharmaceutical Co., Ltd. Acrux DDS Pty Ltd.
US7214506 May, 2017 Terminated-Settled
(13 Nov, 2017)
Kaken Pharmaceutical Co., Ltd. et al. Argentum Pharmaceuticals LLC et al.
US5912238 November, 1997 Decision
(19 Nov, 1997)
DONALD
US5955109 September, 1995 Decision
(18 Sep, 1997)
WON et al


Bausch's Family Patents

Bausch drugs have patent protection in a total of 49 countries. It's US patent count contributes only to 39.3% of its total global patent coverage. 16 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Bausch Drug List

Given below is the complete list of Bausch's drugs and the patents protecting them.


1. Acanya

Acanya is protected by 7 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8288434 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 05 Aug, 2029
(4 years from now)
Active
US10220049 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US10624918 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US8663699 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US8895070 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US9078870 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US5733886 Compositions of clindamycin and benzoyl peroxide for acne treatment 31 Mar, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acanya's drug page


2. Aldara

Aldara is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7696159
(Pediatric)
Treatment for basal cell carcinoma 01 Oct, 2024
(2 months ago)
Expired
US7696159 Treatment for basal cell carcinoma 01 Apr, 2024
(8 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aldara's drug page


3. Aplenzin

Aplenzin is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7241805 Modified release formulations of a bupropion salt 27 Jun, 2026
(1 year, 6 months from now)
Active
US7569610 Modified release formulations of a bupropion salt 27 Jun, 2026
(1 year, 6 months from now)
Active
US7572935 Modified release formulations of a bupropion salt 27 Jun, 2026
(1 year, 6 months from now)
Active
US7585897 Modified release formulations of a bupropion salt 27 Jun, 2026
(1 year, 6 months from now)
Active
US7645802 Bupropion hydrobromide and therapeutic applications 27 Jun, 2026
(1 year, 6 months from now)
Active
US7649019 Modified release formulations of a bupropion salt 27 Jun, 2026
(1 year, 6 months from now)
Active
US7662407 Modified release formulations of a bupropion salt 27 Jun, 2026
(1 year, 6 months from now)
Active
US7671094 Bupropion hydrobromide and therapeutic applications 27 Jun, 2026
(1 year, 6 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aplenzin's drug page


4. Arazlo

Arazlo is protected by 3 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11311482 Topical compositions and methods for treating skin diseases 11 May, 2038
(13 years from now)
Active
US11679116 Topical compositions and methods for treating psoriasis 06 Jun, 2036
(11 years from now)
Active
US6517847 Topical gel delivery system 03 Aug, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arazlo's drug page


5. Bryhali

Bryhali is protected by 7 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10478502 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US11839656 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US11957753 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US11986527 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US12076403 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US8809307 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US6517847 Topical gel delivery system 03 Aug, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bryhali's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Cabtreo

Cabtreo is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11389467 Topical compositions 28 Dec, 2040
(16 years from now)
Active
US8288434 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 05 Aug, 2029
(4 years from now)
Active
US10220049 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US10624918 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US9561208 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cabtreo's drug page


7. Cardizem Cd

Cardizem Cd is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5439689 Diltiazem formulation 08 Aug, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cardizem Cd's drug page


8. Cardizem La

Cardizem La is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6923984 Cushioning wax beads for making solid shaped articles 25 Feb, 2021
(3 years ago)
Expired
US7108866 Chronotherapeutic diltiazem formulations and the administration thereof 17 Dec, 2019
(4 years ago)
Expired
US5529791 Extended release form of diltiazem 25 Jun, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cardizem La's drug page


9. Clindagel

Clindagel is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6387383 Topical low-viscosity gel composition 03 Aug, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clindagel's drug page


10. Diastat

Diastat is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5462740 Rectally-administered, epileptic-seizure-inhibiting composition 17 Sep, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Diastat's drug page


11. Diastat Acudial

Diastat Acudial is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5462740 Rectally-administered, epileptic-seizure-inhibiting composition 17 Sep, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Diastat Acudial's drug page


12. Duobrii

Duobrii is protected by 11 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10251895 Topical compositions and methods for treating psoriasis 06 Jun, 2036
(11 years from now)
Active
US10426787 Topical compositions and methods for treating psoriasis 06 Jun, 2036
(11 years from now)
Active
US11648256 Topical compositions and methods for treating psoriasis 06 Jun, 2036
(11 years from now)
Active
US11679115 Topical compositions and methods for treating psoriasis 06 Jun, 2036
(11 years from now)
Active
US10478502 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US11839656 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US11957753 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US11986527 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US12076403 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US8809307 Pharmaceutical formulations containing corticosteroids for topical administration 02 Nov, 2031
(6 years from now)
Active
US6517847 Topical gel delivery system 03 Aug, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Duobrii's drug page


13. Elidel

Elidel is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6423722
(Pediatric)
Crystalline macrolides and process for their preparation 26 Dec, 2018
(5 years ago)
Expired
US6423722 Crystalline macrolides and process for their preparation 26 Jun, 2018
(6 years ago)
Expired
US5912238
(Pediatric)
Heteroatoms-containing tricyclic compounds 15 Dec, 2016
(7 years ago)
Expired
US5912238 Heteroatoms-containing tricyclic compounds 15 Jun, 2016
(8 years ago)
Expired
US6352998
(Pediatric)
Pharmaceutical compositions 26 Apr, 2016
(8 years ago)
Expired
US6352998 Pharmaceutical compositions 26 Oct, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Elidel's drug page


14. Jublia

Jublia is protected by 18 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10478601 Applicator 25 Apr, 2035
(10 years from now)
Active
US10342875 Stabilized efinaconazole compositions 02 Oct, 2034
(9 years from now)
Active
US10828293 Anti-infective methods, compositions, and devices 02 Oct, 2034
(9 years from now)
Active
US10864274 Stabilized efinaconazole formulations 02 Oct, 2034
(9 years from now)
Active
US11654139 Anti-infective methods, compositions, and devices 02 Oct, 2034
(9 years from now)
Active
US9662394 Stabilized efinaconazole compositions 02 Oct, 2034
(9 years from now)
Active
US8486978 Compositions and methods for treating diseases of the nail 24 Oct, 2030
(5 years from now)
Active
US9302009 Compositions and methods for treating diseases of the nail 24 Oct, 2030
(5 years from now)
Active
US10105444 Compositions and methods for treating diseases of the nail 08 Jul, 2030
(5 years from now)
Active
US8039494 Compositions and methods for treating diseases of the nail 08 Jul, 2030
(5 years from now)
Active
US9861698 Compositions and methods for treating diseases of the nail 08 Jul, 2030
(5 years from now)
Active
US10512640 Compositions and methods for treating diseases of the nail 03 Jan, 2028
(3 years from now)
Active
US10828369 Compositions and methods for treating diseases of the nail 03 Jan, 2028
(3 years from now)
Active
US11213519 Compositions and methods for treating diseases of the nail 03 Jan, 2028
(3 years from now)
Active
US11872218 Compositions and methods for treating diseases of the nail 03 Jan, 2028
(3 years from now)
Active
US9566272 Compositions and methods for treating diseases of the nail 03 Jan, 2028
(3 years from now)
Active
US9877955 Compositions and methods for treating diseases of the nail 03 Jan, 2028
(3 years from now)
Active
US7214506 Method for treating onychomycosis 22 Feb, 2026
(1 year, 2 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jublia's drug page


15. Locoid

Locoid is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7378405 Stabilized steroid composition and method for its preparation 19 Dec, 2026
(2 years from now)
Active
US7981877 Stabilized steroid composition and method for its preparation 23 Jan, 2025
(a month from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Locoid's drug page


16. Loprox

Loprox is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7981909 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis 16 Sep, 2017
(7 years ago)
Expired
US8227490 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis 16 Sep, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Loprox's drug page


17. Luzu

Luzu is protected by 5 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8980931 Method of evaluating pharmaceutical preparation containing luliconazole and index substance 28 Apr, 2034
(9 years from now)
Active
US9012484 Crystal and pharmaceutical preparation containing the same crystal 06 Sep, 2033
(8 years from now)
Active
US9199977 Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal 06 Sep, 2033
(8 years from now)
Active
US9453006 Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient 06 Sep, 2033
(8 years from now)
Active
US5900488 Method for treating mycosis using imidazolylacetonitrile derivatives 18 Jan, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luzu's drug page


18. Metrogel-vaginal

Metrogel-vaginal is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5536743 Intravaginal treatment of vaginal infections with buffered metronidazole compositions 16 Jul, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Metrogel-vaginal's drug page


19. Onexton

Onexton is protected by 6 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8288434 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 05 Aug, 2029
(4 years from now)
Active
US10137142 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US10220049 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US9504704 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US9561208 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent 03 Jun, 2029
(4 years from now)
Active
US5733886 Compositions of clindamycin and benzoyl peroxide for acne treatment 31 Mar, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Onexton's drug page


20. Retin-a Micro

Retin-a Micro is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5955109 Methods and compositions for topical delivery of retinoic acid 21 Sep, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Retin-a Micro's drug page


21. Retin-a-micro

Retin-a-micro is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5955109 Methods and compositions for topical delivery of retinoic acid 21 Sep, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Retin-a-micro's drug page


22. Solodyn

Solodyn is protected by 9 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9192615 Method for the treatment of acne and certain dosage forms thereof 17 Nov, 2031
(6 years from now)
Active
US7541347 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
(2 years from now)
Active
US7544373 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
(2 years from now)
Active
US7919483 Method for the treatment of acne 07 Mar, 2027
(2 years from now)
Active
US7790705 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
(6 months from now)
Active
US8252776 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
(6 months from now)
Active
US8268804 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
(6 months from now)
Active
US8722650 Extended-release minocycline dosage forms 24 Jun, 2025
(6 months from now)
Active
US5908838 Method for the treatment of acne 19 Feb, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Solodyn's drug page


23. Targretin

Targretin is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5962731 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors 05 Oct, 2016
(8 years ago)
Expired
US5780676 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors 14 Jul, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Targretin's drug page


24. Tasmar

Tasmar is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5476875 Catechol derivatives 19 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tasmar's drug page


25. Tiazac

Tiazac is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5529791 Extended release form of diltiazem 25 Jun, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tiazac's drug page


26. Vanos

Vanos is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8232264 Compositions and methods for enhancing corticosteroid delivery 09 Mar, 2023
(1 year, 8 months ago)
Expired
US7220424 Compositions and methods for enhancing corticosteroid delivery 07 Jan, 2023
(1 year, 10 months ago)
Expired
US7794738 Compositions and methods for enhancing corticosteroid delivery 11 Sep, 2022
(2 years ago)
Expired
US6765001 Compositions and methods for enhancing corticosteroid delivery 21 Dec, 2021
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vanos's drug page


27. Virazole

Virazole is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6150337 Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes 21 Nov, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Virazole's drug page


28. Wellbutrin Xl

Wellbutrin Xl is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6096341 Delayed release tablet of bupropion hydrochloride 30 Oct, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wellbutrin Xl's drug page


29. Xerese

Xerese is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7223387 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester 28 Feb, 2021
(3 years ago)
Expired
US6514980 Nucleoside analogs in combination therapy of herpes simplex infections 24 Jan, 2017
(7 years ago)
Expired
USRE39264 Pharmaceutical combination 02 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xerese's drug page


30. Zelapar

Zelapar is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6423342 Process for the preparation of a solid pharmaceutical dosage form 01 Mar, 2016
(8 years ago)
Expired
US5648093 Pharmaceutical and other dosage forms 15 Jul, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zelapar's drug page


31. Ziana

Ziana is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6387383 Topical low-viscosity gel composition 03 Aug, 2020
(4 years ago)
Expired
USRE41134 Slow release vehicles for minimizing skin irritancy of topical compositions 24 Feb, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ziana's drug page


32. Zyclara

Zyclara is protected by 10 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10918635 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 30 Apr, 2030
(5 years from now)
Active
US11202752 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy 30 Apr, 2030
(5 years from now)
Active
US11850245 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 30 Apr, 2030
(5 years from now)
Active
US10238644 2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod 11 Dec, 2029
(5 years from now)
Active
US11318130 2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod 11 Dec, 2029
(5 years from now)
Active
US8222270 2×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod 11 Dec, 2029
(5 years from now)
Active
US8236816 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod 11 Dec, 2029
(5 years from now)
Active
US8299109 Method of treating actinic keratosis with 3.75% imiquimod cream 11 Dec, 2029
(5 years from now)
Active
US10238645 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 18 Aug, 2029
(4 years from now)
Active
US8598196 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy 18 Aug, 2029
(4 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zyclara's drug page


Bausch News

The US Supreme Court decides not to review patent clash involving popular Bausch diarrhea medication

18 Nov, 2024

Formosa Pharma announces approval of Eyenovia's eye medication by US FDA

05 Mar, 2024

See More